[Modulation of hCG synthesis by alpha tumor necrosis factor in JAR choriocarcinoma cells]. 1990

C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
Universitätsklinik für Frauenheilkunde, Osterreichischen Akademie der Wissenschaften, Innsbruck.

The tumour necrosis factor (TNF) stimulates in cultured JAR choriocarcinoma cells the biosynthesis of hCG, including the free alpha and beta chain and the holo-hCG. Although elevated serum TNF levels have been shown by Balkwill et al. (1987) in about 50% of tumour patients, we were unable to confirm these data in the 10 examined patients, who had a choriocarcinoma. Despite its excellent in-vitro action, INF could not be confirmed to exercise an influence on the regulation of hCG in choriocarcinoma patients.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D005260 Female Females
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
October 1989, Biochemical and biophysical research communications,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
January 2000, Life sciences,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
January 1988, Haematologica,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
January 1996, Anticancer research,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
March 1994, In vitro cellular & developmental biology. Animal,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
December 1988, Endocrinology,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
June 1989, Nihon Sanka Fujinka Gakkai zasshi,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
May 1995, Journal of reproductive immunology,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
September 1991, Biulleten' eksperimental'noi biologii i meditsiny,
C Marth, and S Madersbacher, and M Herold, and P Berger, and H Hetzel, and L C Fuith, and G Daxenbichler
October 1978, Biochemical and biophysical research communications,
Copied contents to your clipboard!